William R Larue - Net Worth and Insider Trading
William R Larue Net Worth
The estimated net worth of William R Larue is at least $22 dollars as of 2024-11-13. William R Larue is the Director of TRACON Pharmaceuticals Inc and owns about 388 shares of TRACON Pharmaceuticals Inc (TCON) stock worth over $22. Details can be seen in William R Larue's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William R Larue has not made any transactions after 2022-12-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William R Larue
William R Larue Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William R Larue owns 3 companies in total, including Oncternal Therapeutics Inc (ONCT) , TRACON Pharmaceuticals Inc (TCON) , and Histogen Inc (HSTO) .
Click here to see the complete history of William R Larue’s form 4 insider trades.
Insider Ownership Summary of William R Larue
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ONCT | Oncternal Therapeutics Inc | 2019-06-07 | director |
| TCON | TRACON Pharmaceuticals Inc | 2022-12-21 | director |
| HSTO | Histogen Inc | 2017-02-06 | director |
William R Larue Latest Holdings Summary
William R Larue currently owns a total of 1 stock. William R Larue owns 388 shares of TRACON Pharmaceuticals Inc (TCON) as of December 21, 2022, with a value of $22.
Latest Holdings of William R Larue
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCON | TRACON Pharmaceuticals Inc | 2022-12-21 | 388 | 0.06 | 22 |
Holding Weightings of William R Larue
William R Larue Form 4 Trading Tracker
According to the SEC Form 4 filings, William R Larue has made a total of 2 transactions in TRACON Pharmaceuticals Inc (TCON) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in TRACON Pharmaceuticals Inc is the sale of 6 shares on December 21, 2022, which brought William R Larue around $151.
Insider Trading History of William R Larue
- 1
William R Larue Trading Performance
GuruFocus tracks the stock performance after each of William R Larue's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William R Larue is -7.61%. GuruFocus also compares William R Larue's trading performance to market benchmark return within the same time period. The performance of stocks bought by William R Larue within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William R Larue's insider trading performs compared to the benchmark.
Performance of William R Larue
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.26 | | | | | |
| Relative Return to S&P 500(%) | -1.34 | | | | | |
William R Larue Ownership Network
Ownership Network List of William R Larue
Ownership Network Relation of William R Larue
William R Larue Owned Company Details
What does Oncternal Therapeutics Inc do?
Who are the key executives at Oncternal Therapeutics Inc?
William R Larue is the director of Oncternal Therapeutics Inc. Other key executives at Oncternal Therapeutics Inc include director & Executive Chairman Robert James Wills , Chief Scientific Officer Gunnar F. Kaufmann , and Chief Medical Officer Salim Yazji .
Oncternal Therapeutics Inc (ONCT) Insider Trades Summary
Over the past 18 months, William R Larue made no insider transaction in Oncternal Therapeutics Inc (ONCT). Other recent insider transactions involving Oncternal Therapeutics Inc (ONCT) include a net purchase of 9,020 shares made by Robert James Wills , a net purchase of 28,000 shares made by Gunnar F. Kaufmann , and a net purchase of 980 shares made by David F Hale .
In summary, during the past 3 months, insiders sold 0 shares of Oncternal Therapeutics Inc (ONCT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 980 shares of Oncternal Therapeutics Inc (ONCT) were sold and 12,380 shares were bought by its insiders, resulting in a net purchase of 11,400 shares.
Oncternal Therapeutics Inc (ONCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oncternal Therapeutics Inc Insider Transactions
William R Larue Mailing Address
Above is the net worth, insider trading, and ownership report for William R Larue. You might contact William R Larue via mailing address: C/o Tracon Pharmaceuticals, Inc., 8910 University Center Lane, Suite 700, San Diego Ca 92122.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
